KR20240036651A - 산화성 망막 질환의 진행을 억제하는 방법 - Google Patents

산화성 망막 질환의 진행을 억제하는 방법 Download PDF

Info

Publication number
KR20240036651A
KR20240036651A KR1020247005941A KR20247005941A KR20240036651A KR 20240036651 A KR20240036651 A KR 20240036651A KR 1020247005941 A KR1020247005941 A KR 1020247005941A KR 20247005941 A KR20247005941 A KR 20247005941A KR 20240036651 A KR20240036651 A KR 20240036651A
Authority
KR
South Korea
Prior art keywords
day
progression
patient
ester
rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247005941A
Other languages
English (en)
Korean (ko)
Inventor
카르스텐 슈미트
미하일 셰피노브
Original Assignee
바이오지바 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오지바 엘엘씨 filed Critical 바이오지바 엘엘씨
Publication of KR20240036651A publication Critical patent/KR20240036651A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020247005941A 2021-07-22 2022-07-22 산화성 망막 질환의 진행을 억제하는 방법 Pending KR20240036651A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163224690P 2021-07-22 2021-07-22
US202163224679P 2021-07-22 2021-07-22
US202163224674P 2021-07-22 2021-07-22
US63/224,679 2021-07-22
US63/224,690 2021-07-22
US63/224,674 2021-07-22
PCT/US2022/038072 WO2023004151A1 (en) 2021-07-22 2022-07-22 Methods for inhibiting the progression of oxidative retinal diseases

Publications (1)

Publication Number Publication Date
KR20240036651A true KR20240036651A (ko) 2024-03-20

Family

ID=84979648

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247005941A Pending KR20240036651A (ko) 2021-07-22 2022-07-22 산화성 망막 질환의 진행을 억제하는 방법

Country Status (8)

Country Link
US (1) US20250099415A1 (https=)
EP (1) EP4373479A4 (https=)
JP (1) JP2024526939A (https=)
KR (1) KR20240036651A (https=)
AU (1) AU2022313207A1 (https=)
CA (1) CA3227139A1 (https=)
IL (1) IL310210A (https=)
WO (1) WO2023004151A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024049497A1 (en) * 2022-09-02 2024-03-07 Biojiva Llc Pharmaceutical compositions of d10-docosahexaenoic acid or esters thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060270739A1 (en) * 2005-04-28 2006-11-30 Trustees Of Tufts College Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation
CA2723139A1 (en) * 2007-07-30 2009-02-05 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells
WO2009058815A2 (en) * 2007-10-29 2009-05-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Lipoxin a4 protection for retinal cells
EP3689342A1 (en) * 2011-04-26 2020-08-05 Retrotope, Inc. Oxidative retinal diseases
CA3005983A1 (en) * 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
CA3117216A1 (en) * 2018-11-15 2020-05-22 Retrotope, Inc. Deuterated compounds, compositions, and uses

Also Published As

Publication number Publication date
EP4373479A4 (en) 2025-11-05
EP4373479A1 (en) 2024-05-29
US20250099415A1 (en) 2025-03-27
IL310210A (en) 2024-03-01
AU2022313207A1 (en) 2024-02-29
CA3227139A1 (en) 2023-01-26
WO2023004151A1 (en) 2023-01-26
JP2024526939A (ja) 2024-07-19

Similar Documents

Publication Publication Date Title
EP3735963B1 (en) Self-emulsifying composition of omega-3 fatty acid
CN102088978B (zh) 血脂异常症的改善或治疗药
JP6092843B2 (ja) 神経障害の治療用組成物
US6852870B2 (en) Omega-3 fatty acids in the treatment of depression
HUP0200111A2 (hu) Esszenciális zsírsavak alkalmazása a cardiovascularis események megelőzésében alkalmazható gyógyszerkészítmények előállítására
KR20230004545A (ko) Lpc-dha 및 lpc-epa가 풍부한 크릴 오일 조성물
JP2022502471A (ja) 化学療法誘発性の悪心および嘔吐を治療するための方法および製剤
KR20240036651A (ko) 산화성 망막 질환의 진행을 억제하는 방법
US20230255917A1 (en) Methods of treating amyotrophic lateral sclerosis
US11602510B2 (en) Agent for use in the treatment of dyslipidemia
CN118019529A (zh) 抑制氧化性视网膜疾病进展的方法
US20250241884A1 (en) Pharmaceutical Compositions of D10-Docosahexaenoic Acid or Esters Thereof
JP2004115429A (ja) 視力向上剤
US20200085774A1 (en) Omega-3 Fatty Acid Composition for Preventing and/or Treating Cachexia
JP2025507361A (ja) 網膜酸化的疾患の治療に対する患者の反応をモニタリングする方法
AU2005265998A1 (en) Compositions and methods for smoking cessation
JPH0319208B2 (https=)
JP2025506208A (ja) Ａｌｓ治療のための相乗的併用療法
KR20260010331A (ko) L-세린의 리포좀 제형 및 이의 제조 방법
EP4717261A1 (en) Pharmaceutical compositions of 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
JPH05139966A (ja) 月経困難症予防または治療剤と月経困難症予防機能性食品
JP2000327571A (ja) 抗かゆみ組成物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240221

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250604

Comment text: Request for Examination of Application